Hematology

Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. MM accounts…

Many T cell leukaemia patients could be treated by a drug which suppresses the BCL-2 protein, according to researchers from KU Leuven, Leuven, Belgium.

Celebral malaria mortality rates have been significantly reduced in mice through the use of a novel treatment method developed by scientists from the…

Multiple myeloma is increasingly being recognised as more than one disease, characterised by marked cytogenetic, molecular, and proliferative heterogeneity.

New insights into the ecology of a potentially fatal haemorrhagic fever virus have been provided by researchers from Uppsala University, Uppsala…

The world-renowned Stockholmsmässan congress centre in Stockholm, Sweden, will host this year’s EHA Congress, which promises to be a particularly…

The parasite Plasmodium vivax is responsible for the majority of malaria cases outside of sub-Saharan Africa, and research conducted at Harvard T.H. Chan…